Nvidia among investors in xAI’s $20 bln capital raise- Bloomberg
Director Lawrence Sandra AJ sold 3,899 shares of SERA Prognostics Inc (NASDAQ:SERA) Class A Common Stock on September 9, 2025, for approximately $11,891. The micro-cap biotech company, valued at $117 million, maintains a strong balance sheet with more cash than debt, though InvestingPro analysis indicates the company is burning through cash rapidly.
The shares were sold at a weighted average price of $3.05, with individual sales prices ranging from $2.99 to $3.12. Following the transaction, Lawrence Sandra AJ directly owns 18,814 shares of the company. Currently trading at $3.10, SERA’s stock has shown significant volatility, with prices ranging from $1.37 to $9.13 over the past year. According to InvestingPro’s Fair Value model, the stock appears fairly valued. Discover more insights and 8 additional key ProTips with a comprehensive Pro Research Report, available exclusively on InvestingPro.
In other recent news, Sera Prognostics announced its second quarter 2025 earnings, reporting an earnings per share (EPS) of -$0.16, which was better than the expected -$0.23. Despite this positive earnings surprise, the company’s revenue was significantly below expectations, totaling $17,000 compared to the anticipated $100,000. This discrepancy highlights a substantial shortfall in revenue performance. The earnings report indicates that while the company managed to exceed EPS forecasts, revenue generation remains a challenge. These recent developments provide insights into the company’s financial health and operational performance. Investors will be closely monitoring how Sera Prognostics addresses its revenue challenges moving forward.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.